Author's Reply to Srinivas: "Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Modeling of Filgotinib (GLPG0634), a Selective JAK1 Inhibitor, in Support of Phase IIB Dose Selection".

Article Details

Citation

Copy to clipboard

Namour F

Author's Reply to Srinivas: "Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Modeling of Filgotinib (GLPG0634), a Selective JAK1 Inhibitor, in Support of Phase IIB Dose Selection".

Clin Pharmacokinet. 2015 Dec;54(12):1297-8. doi: 10.1007/s40262-015-0336-5.

PubMed ID

26482170 [ View in PubMed

]

Abstract

Not Available

DrugBank Data that Cites this Article

Drugs

Filgotinib

Drug Enzymes

Drug	Enzyme	Kind	Organism	Pharmacological Action	Actions
Filgotinib	Cocaine esterase	Protein	Humans	Unknown	Metabolizer	Details
Filgotinib	Liver carboxylesterase 1	Protein	Humans	Unknown	Metabolizer	Details

Drug Reactions

Reaction
Filgotinib DB14845 Cocaine esterase Liver carboxylesterase 1 GS-829845 DBMET03213	Details